Correlation of Epigenetic Aberrance with STAT3 Signaling Pathway in Gastric Carcinogenesis
Abstract
Background
It has been suggested that STAT3 signaling plays important roles in regulating epigenetic aberrance during tumorigenesis, especially in the expression of certain key epigenetic enzymes such as DNMTs, HDACs, and HMTs. However, there has been no report on the relationship of STAT3 signaling and epigenetic aberrance in gastrocarcinogenesis.
Aim
The purpose of this study was to explore the interrelationship of STAT3 signaling pathway and epigenetic aberrance in gastrocarcinogenesis.
Methods
Immunohistochemistry was utilized to examine the protein expressions of pSTAT3, DNMT1, HDAC1, and EZH2 in 153 tissue specimens, including 20 of normal gastric epithelium tissue, 21 of intestinal metaplasia (IM), 24 of dysplasia (DYS), 23 of early gastric cancer (EGC) and 65 of advanced gastric cancer (AGC), and then analyze their possible relationship with clinicopathological factors.
Results
We found that the four protein expressions were obviously enhanced following the malignant process of gastric carcinogenesis. Pearson correlation analysis of all the pathological groups showed that expression of pSTAT3 was highly associated with DNMT1, but not with HADC1 and EZH2. However, significant correlations were detected among the expression of DNMT1, HDAC1, and EZH2. Further analysis of each pathological group demonstrated that pSTAT3’s expression was dramatically related with DNTM1 in the IM (P = 0.021) and EGC groups (P = 0.013) and correlated with EZH2 in the DYS group (P = 0.020). Furthermore, pSTAT3’s expression was associated with T staging (P = 0.015) in the AGC group, whereas DNMT1 was associated with gender (P = 0.021), HDAC1 with Lauren classification (P = 0.007), and EZH2 with T staging (P = 0.003) and lymphatic staging (P = 0.038).
Conclusions
The STAT3 signaling pathway may correlate with epigenetic aberrance during gastrocarcinogenesis.
Keywords
STAT3 Epigenetics Precancerous lesion Gastric cancerNotes
Acknowledgments
This work was supported by Nanjing Medical Technology Development Project (No. YKK08066). We thank Jun Yang and Qiang Zhou in the Department of Pathology for expert technical assistance in performing the experiments outlined here.
Conflict of interest
The authors declare that they have no conflict of interest.
References
- 1.No authors listed. Gastric cancer incidence rate to rise. Manag Care. 2010;19:49.Google Scholar
- 2.Correa P. Helicobacter pylori and gastric carcinogenesis. Am J Surg Pathol. 1995;19:S37–S43.PubMedCrossRefGoogle Scholar
- 3.Fukayama M. Epstein–Barr virus and gastric carcinoma. Pathol Int. 2010;60:337–350.PubMedCrossRefGoogle Scholar
- 4.Chao C, Hellmich MR. Gastrin, inflammation, and carcinogenesis. Curr Opin Endocrinol Diabetes Obes. 2010;17:33–39.PubMedGoogle Scholar
- 5.Sharma S, Kelly TK, Jones PA. Epigenetics in cancer. Carcinogenesis. 2010;31:27–36.PubMedCrossRefGoogle Scholar
- 6.Etoh T, Kanai Y, Ushijima S, et al. Increased DNA methyltransferase 1 (DNMT1) protein expression correlates significantly with poorer tumor differentiation and frequent DNA hypermethylation of multiple CpG islands in gastric cancers. Am J Pathol. 2004;164:689–699.PubMedCrossRefGoogle Scholar
- 7.Mutze K, Langer R, Becker K, et al. Histone deacetylase (HDAC) 1 and 2 expression and chemotherapy in gastric cancer. Ann Surg Oncol. 2010;17:3336–3343.PubMedCrossRefGoogle Scholar
- 8.Matsukawa Y, Semba S, Kato H, Ito A, Yanagihara K, Yokozaki H. Expression of the enhancer of zeste homolog 2 is correlated with poor prognosis in human gastric cancer. Cancer Sci. 2006;97:484–491.PubMedCrossRefGoogle Scholar
- 9.Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood. 2006;108:1058–1064.PubMedCrossRefGoogle Scholar
- 10.Gupta M, Stenson M, Lasho T, et al. Interplay between histone deacetylases (HDACs) and STAT3: mechanism of activated JAK/STAT3 oncogenic pathway in ABC (activated B-cell) type diffuse large B cell lymphoma. Abstract 925. Blood. 2009;114:381.Google Scholar
- 11.Yeh HY, Cheng SW, Lin YC, Yeh CY, Lin SF, Soo VW. Identifying significant genetic regulatory networks in the prostate cancer from microarray data based on transcription factor analysis and conditional independency. BMC Med Genomics. 2009;2:70.PubMedCrossRefGoogle Scholar
- 12.Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988;48:3554–3560.PubMedGoogle Scholar
- 13.Yakata Y, Nakayama T, Yoshizaki A, Kusaba T, Inoue K, Sekine I. Expression of pSTAT3 in human gastric carcinoma: significant correlation in tumour invasion and prognosis. Int J Oncol. 2007;30:437–442.PubMedGoogle Scholar
- 14.Jackson CB, Giraud AS. STAT3 as a prognostic marker in human gastric cancer. J Gastroenterol Hepatol. 2009;24:505–507.PubMedCrossRefGoogle Scholar
- 15.Deng JY, Sun D, Liu XY, Pan Y, Liang H. STAT-3 correlates with lymph node metastasis and cell survival in gastric cancer. World J Gastroenterol. 2010;16:5380–5387.PubMedCrossRefGoogle Scholar
- 16.Zhang Q, Wang HY, Woetmann A, Raghunath PN, Odum N, Wasik MA. STAT3 induces transcription of the DNA methyltransferase 1 gene (DNMT1) in malignant T lymphocytes. Blood. 2006;108:1058–1064.PubMedCrossRefGoogle Scholar
- 17.Zhang Q, Wang HY, Marzec M, Raghunath PN, Nagasawa T, Wasik MA. STAT3—and DNA methyltransferase 1-mediated epigenetic silencing of SHP-1 tyrosine phosphatase tumor suppressor gene in malignant T lymphocytes. Proc Natl Acad Sci USA. 2005;102:6948–6953.PubMedCrossRefGoogle Scholar
- 18.Schuettengruber B, Simboeck E, Khier H, Seiser C. Autoregulation of mouse histone deacetylase 1 expression. Mol Cell Biol. 2003;23:6993–7004.PubMedCrossRefGoogle Scholar
- 19.Kang GH, Lee S, Kim JS, Jung HY. Profile of aberrant CpG island methylation along the multistep pathway of gastric carcinogenesis. Lab Invest. 2003;83:635–641.PubMedGoogle Scholar
- 20.Zou XP, Zhang B, Zhang XQ, Chen M, Cao J, Liu WJ. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol. 2009;40:1534–1542.PubMedCrossRefGoogle Scholar
- 21.Zeng J, Ge Z, Wang L, et al. The histone demethylase RBP2 is overexpressed in gastric cancer and its inhibition triggers senescence of cancer cells. Gastroenterology. 2010;138:981–992.PubMedCrossRefGoogle Scholar
- 22.Weichert W, Röske A, Gekeler V, et al. Association of patterns of class I histone deacetylase expression with patient prognosis in gastric cancer: a retrospective analysis. Lancet Oncol. 2008;9:139–148.PubMedCrossRefGoogle Scholar
- 23.Choi JH, Song YS, Yoon JS, Song KW, Lee YY. Enhancer of zeste homolog 2 expressions is associated with tumor cell proliferation and metastasis in gastric cancer. APMIS. 2010;118:196–202.PubMedCrossRefGoogle Scholar
- 24.Meng CF, Zhu XJ, Peng G, et al. Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. Cancer Invest. 2010;28:331–339.PubMedGoogle Scholar
- 25.Ding WJ, Fang JY, Chen XY, Peng YS. The expression and clinical significance of DNA methyltransferase proteins in human gastric cancer. Dig Dis Sci. 2008;53:2083–2089.PubMedCrossRefGoogle Scholar